Stroke in atrial fibrillation - Hope on the horizon?

Journal of the Royal Society Interface

Volumn 7, Issue SUPPL. 6, 2010, Pages

  Jamil Copley, Shahnaz ^a   Kanagaratnam, Prapa ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Atrial fibrillation; Stroke; Watchman

Indexed keywords

DRUG INTERACTIONS; DRUG THERAPY;

ANTI-COAGULATION; ATRIAL FIBRILLATION; BLOOD LEVELS; CARDIAC ARRHYTHMIA; CLINICAL USE; FOOD INTERACTIONS; HUMAN USE; RISK REDUCTIONS; STROKE; WATCHMAN; WORLD POPULATION;

DISEASES;

ACETYLSALICYLIC ACID; DABIGATRAN; WARFARIN;

ANTICOAGULATION; BRAIN HEMORRHAGE; DEVICE; HEART ARRHYTHMIA; HEART ATRIUM CONTRACTION; HEART ATRIUM FIBRILLATION; HUMAN; REVIEW; RISK REDUCTION; STROKE; THROMBOEMBOLISM;

EID: 78649813991     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2010.0344.focus     Document Type: Review

References (27)

1. Aberg, H. 1969 Atrial Fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med. Scand. 185, 373-379. (doi:10.1111/j.0954-6820.1969.tb07351.x)
2. Al-Saady, N. M., Obel, O. A. & Camm, A. J. 1999 Left atrial appendage: structure, function and role in thromboembolism. Heart 82, 547-554. (doi:10.1136/hrt.82.5.547)
3. Birman-Deych, E., Radford, M., Nilasena, D. S. & Gage, B. F. 2006 Use and effectiveness of warfarin in medicare benefi- ciaries with atrial fibrillation. Stroke 37, 1070-1074. (doi:10.1161/01.STR.0000208294.46968.a4)
4. Blackshear, J. L. & Odel, J. A. 1996 Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann. Thorac. Surg. 61, 755-759. (doi:10.1016/0003-4975(95)00887-X)
5. Connolly, S., Ezekowitz, M., Yusuf, S., Eikelboom, J. & RE-LY steering committee and investigators 2009 Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 361, 1139-1151.
6. Falk, R. H. 2001 Atrial fibrillation. N. Engl. J. Med. 344, 1067-1078. (doi:10.1056/NEJM200104053441407)
7. Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W. & Radford, M. J. 2001 Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. J. Am. Med. Assoc. 285, 2864-2870. (doi:10.1001/jama.285.22.2864)
8. Go, A. S., Hylek, E. M., Borowsky, L. H., Phillips, K. A., Selby, J. V. & Singer, D. E. 1999 Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann. Intern. Med. 131, 927-934.
9. Heerimga, J., van der Kuip, D. A., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H. Ch., Stijnen, T., Lip, G. Y. H. & Witteman, J. C. M. 2006 Prevalence, incidence and lifetime risk of developing atrial fibrillation: the Rotterdam Study. Eur. Heart J. 27, 949-953. (doi:10.1093/eurheartj/ehi825)
10. Heuschmann, P. U., Kolominsky-Rabas, P. L., Kremer, R. & Neundörfer, B. 1998 Pflege- und Versorgungsbedarf nach schlaganfall am beispiel des populationsbasierten Erlanger schlaganfall projektes. Akt Neurologie 25(Suppl. 3), 168.
11. Holmes, D. R., Reddy, V. Y., Turi, Z. G., Doshi, S. K., Sievert, H., Buchbinder, M., Mullin, C. M., Sick, P. & Protect AF Investigators 2009 Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374, 534-542. (doi:10.1016/S0140-6736(09)61343-X)
12. Hylek, E. M., Go, A. S., Chang, Y., Jensvold, N. G., Henault, L. E., Selby, J. V. & Singer, D. E. 2003 Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N. Engl. J. Med. 349, 1019-1026. (doi:10.1056/NEJMoa022913)
13. Hylek, E. M., D'Antonio, J., Evans-Molina, C., Shea, C., Henault, L. E. & Regan, S. 2006 Translating the results of randomized trials into clinical practice. The challenge of warfarin candidacy among hospitalised elderly patients with atrial fibrillation. Stroke 37, 1075-1080. (doi:10.1161/01.STR. 0000209239.71702.ce)
14. Lip, G., Kakar, P. & Watson, T. 2007 Atrial fibrillation - the growing epidemic. Heart 93, 542-543. (doi:10.1136/hrt.2006.110791)
15. Lloyd-Jones, D. M. et al. 2004 Lifetime risk for development of atrial fibrillation: the Framingham heart study. Circulation 110, 1042-1046. (doi:10.1161/01.CIR.0000140263.20897.42)
16. Manning, W. J., Weintraub, R. M., Waksmonski, C. A., Haering, J. M., Rooney, P. S., Maslow, A. D., Johnson, R. D. & Douglas, P. S. 1995 Accuracy of transoesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann. Intern. Med. 123, 817-822.
17. McCormick, D., Gurwitz, J. H., Goldberg, R. J., Becker, R., Tate, J. P., Elwell, A. & Radford, M. J. 2001 Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch. Intern. Med. 16, 2458-2463.
18. Muller, I., Massberg, S., Zierhut, W., Binzc, C., Schusterd, A., Rüdiger-von Hochc, S., Braunb, S. & Gawaza, M. 2002 Effects of aspirin and clopidogrel versus oral anticoagulation on platelet function and on coagulation in patients with nonvalvular atrial fibrillation (CLAFIB). Pathophysiol. Haemost. Thromb. 32, 16-24. (doi:10.1159/000057284)
19. National Institute for Health and Clinical Excellence. 2006 The management of atrial fibrillation. Clinical guideline CG036. London, UK: NICE.
20. Niewlaat, R. et al. 2006 Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur. Heart J. 27, 3018-3026. (doi:10.1093/eurheartj/ehl015)
21. Ostermayer, S. H. et al. 2005 Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multicenter feasibility trials. J. Am. Coll. Cardiol. 46, 9-14. (doi:10.1016/j.jacc.2005.03.042)
22. Reddy, V. Y., Neuzil, P., Sick, P. & Sievert, H. 2010 LAA closure using the Watchman device in patients with contraindications to warfarin: preliminary results from the 'ASA Plavix Registry' (ASAP). Poster p05-57 Presented at the Heart Rhythm Society 31st Annual Scientific Sessions, Denver, Colorado, May, 2010.
23. Scottish Intercollegiate Guidelines Network. 2007 Cardiac arrhythmias in coronary heart disease. Clinical guideline 94. Edinburgh, UK: SIGN.
24. Sievert, H. et al. 2002 Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 105, 1887-1889. (doi:10.1161/01.CIR. 0000015698.54752.6D)
25. Tsai, L. M., Chen, J. H., Lin, L. J. & Yang, Y. J. 1990 Role of transoesophageal echocardiography in detecting left atrial thrombus and spontaneous echo contrast in patients with mitral valve disease or nonrheumatic atrial fibrillation. J. Formos. Med. Assoc. 89, 270-274.
26. Waldo, A. L., Becker, R. C., Tapson, V. F., Colgan, K. J. & NABOR Steering Committee. 2005 Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J. Am. Coll. Cardiol. 46, 1729-1736. (doi:10.1016/j.jacc.2005.06.077)
27. Wolf, P. A., Abbott, R. D. & Kannel, W. B. 1991 Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22, 982-988.